Caribou Biosciences Inc.
CRBU | NASDAQ
$1.34
+$0.04 (+3.08%)
Sep 22, 2026, 10:51 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 11.16M | 9.99M | 34.48M | 13.85M | 9.6M | 12.36M |
Cost of Revenue | 3.65M | 3.93M | 3.53M | 3.64M | 984K | 34.43M |
Gross Profit | 7.51M | 6.07M | 30.95M | 10.21M | 8.61M | -22.06M |
Operating Income | -136.19M | -166.62M | -116.06M | -106.4M | -66.98M | -36.12M |
Interest Income | 8M | n/a | 10.7M | 4.6M | 148K | 236K |
Pretax Income | -148.68M | -149.11M | -101.88M | -99.35M | -66.6M | -36.13M |
Net Income | -148.13M | -149.11M | -102.07M | -99.42M | -66.92M | -34.31M |
Selling & General & Admin | 37.91M | 46.46M | 38.46M | 38.02M | 23.34M | 14.06M |
Research & Development | 109.44M | 130.15M | 112.08M | 82.23M | 52.26M | 34.43M |
Other Expenses | -3.65M | -3.93M | -3.53M | -3.64M | n/a | -34.43M |
Operating Expenses | 143.71M | 172.68M | 147.01M | 116.61M | 75.59M | 14.06M |
Interest Expense | n/a | n/a | n/a | n/a | 8K | 20K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 147.35M | 176.61M | 150.54M | 120.25M | 76.58M | 48.49M |
Income Tax Expense | -550K | -9K | 193K | 70K | 321K | -1.82M |
Shares Outstanding (Basic) | 93.39M | 90.32M | 73.81M | 60.8M | 60.26M | 27.66M |
Shares Outstanding (Diluted) | 93.39M | 90.32M | 73.81M | 60.8M | 60.26M | 27.66M |
EPS (Basic) | -1.59 | -1.65 | -1.38 | -1.64 | -1.11 | -1.24 |
EPS (Diluted) | -1.59 | -1.65 | -1.38 | -1.64 | -1.11 | -1.24 |
EBITDA | -145.03M | -145.19M | -98.35M | -95.71M | -65.61M | -35.21M |
EBIT | -148.68M | -149.11M | -101.88M | -99.35M | -66.59M | -36.11M |
Depreciation & Amortization | 3.65M | 3.93M | 3.53M | 3.64M | 984K | 900K |
Add to Watchlist
Select watchlists to add or remove CRBU